Health officials enlist police in growing meningitis scare NASHVILLE, Tennessee (Reuters) - Health authorities scrambled on Monday to identify more cases of a rare form of meningitis, including enlisting local police to find people who might be infected by tainted steroid injections that have so far killed seven people. The U.S. Centers for Disease Control reported 91 cases in nine states on Sunday, up from 64 on Saturday. The widening outbreak has alarmed federal and state health officials and focused attention on regulation of pharmaceutical compounding companies like the one that produced the drugs, the New England Compounding Center Inc in Framingham, Massachusetts. In Ohio, health officials said Monday they are mobilizing community resources, including sheriff's offices, to check on patients who have received the injections. "If that means knocking on doors, then that's what they will do," said Beth Bickford, executive director at the Association of Ohio Health Commissioners, in a statement Monday. The state has so far reported one case of fungal meningitis likely caused by a tainted epidural steroid injection. The company shipped 17,676 vials of the steroid methylprednisolone acetate to 76 facilities in 23 states from July through September, the Massachusetts Health Department said. The steroid is used as a painkiller, usually for the back, and could have been injected in thousands of patients, authorities have said. Meningitis is an infection of the membranes covering the brain and spinal cord, and affected patients started showing a variety of symptoms from one to four weeks after their injections. The company, which was previously the subject of complaints, has suspended its operations while an investigation proceeds and earlier recalled the three lots of the drug. It expanded its recall on Saturday to all products compounded and distributed at its Framingham facility. Complaints against the company in 2002 and 2003 about the processing of medication resulted in an agreement with government agencies in 2006 to correct deficiencies, the Massachusetts Health Department said. The U.S. Food and Drug administration has limited authority over the day-to-day operations of compounding pharmacies, which are regulated primarily by state boards that oversee the practices, licensing and certification of pharmacies and pharmacists. Compounded products do not have to win FDA approval before they are sold, and the agency has no jurisdiction over how the products are manufactured or labeled for use. Instead, the FDA investigates cases of adulterated drugs in cooperation with state regulators. The FDA has tried to exert greater authority over compounded drug products under a section of the Food, Drug and Cosmetic Act that covers new drugs. But those efforts led to federal court challenges that resulted in two separate and conflicting rulings at the appellate level. The nine states where fungal meningitis cases have been reported are Florida, Indiana, Maryland, Michigan, Minnesota, North Carolina, Ohio, Tennessee and Virginia. Tennessee, where the outbreak was first detected, accounted for most of the cases, with 32, including three deaths. Many patients there remain hospitalized, some in critical condition. Michigan had 20 cases and two deaths. One person died in Maryland and another in Virginia, the CDC said. Fungal meningitis is not contagious, the CDC said. Symptoms include fever, headache, nausea and neurological problems that would be consistent with deep brain stroke. The steroid was sent to California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia and West Virginia, the CDC said. A list of facilities that received vials from the infected lots can be found via the website www.cdc.gov. Reporting By Tim Ghianni; Writing by Mary Wisniewski; Editing by Greg McCune and Cynthia Osterman